Treatment of infant acute lymphoblastic leukemia in Japan

International Journal of Hematology

Volumn 69, Issue 4, 1999, Pages 244-252

  Nishimura, Shin Ichiro ^a   Kobayashi, Masao ^a   Ueda, Kazuhiro ^a   Ishii, Eiichi ^b   Okamura, Jun ^c   Kawa Ha, Keisei ^d   Akiyama, Yuichi ^e   Imashuku, Shinsaku ^f   Horibe, Keizo ^g   Matsuyama, Takaharu ^h   Shibuya, Atsushi ⁱ   Imaizumi, Masue ^j   Tsukimoto, Ichiro ^k   Nagao, Takeshi ^l  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Saga Prefectural Hospital   (Japan)

^c NATIONAL KYUSHU CANCER CENTER   (Japan)

^d RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f Kyoto City Institute of Health and Environmental Sciences   (Japan)

^g NAGOYA UNIVERSITY   (Japan)

^h JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

ⁱ SAITAMA MEDICAL UNIVERSITY   (Japan)

^j TOHOKU UNIVERSITY   (Japan)

^k TOHO UNIVERSITY   (Japan)

^l KANAGAWA CHILDREN'S MEDICAL CENTER   (Japan)

more..

Author keywords

11q23 MLL; Acute lymphoblastic leukemia; Chemotherapy; Infant leukemia

Indexed keywords

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; FEMALE; HUMAN; INFANT; JAPAN; MALE; NEWBORN;

FEMALE; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE;

EID: 0033142433     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Leverger G, Bancillon A, Schaison G, et al. Acute lymphoblastic leukemia in very young children. Diagnostic and therapeutic aspects of 43 cases. Am J Pediatr Hematol Oncol 1986;8:213-9.
2. Crist W, Pullen J, Boyett J, et al. Clinical and biologic features predict a poor prognosis in acute lymphoid leukemias in infants: a Pediatric Oncology Group study. Blood 1986;67:135-40.
3. Ishii E, Okamura J, Tsuchida M, et al. Infant leukemia in Japan: clinical and biological analysis of 48 cases. Med Pediatr Oncol 1991;19:28-32.
4. Chessells JM, Eden OB, Bailey CC, et al. Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia. Leukemia 1994;8:1275-9.
5. Ferster A, Bertrand Y, Benoit Y, et al. Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC-Childhood Leukaemia Cooperative Group. Br J Haematol 1994;86:284-90.
6. Pui CH, Rivera GK, Hancock ML, et al. Clinical significance of CD10 expression in childhood acute lymphoblastic leukemia. Leukemia 1993;7:35-40.
7. Pui CH, Kane JR, Crist WM. Biology and treatment of infant leukemias. Leukemia 1995;9:762-9.
8. Chen CS, Sorensen PH, Domer PH, et al. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood 1993;81:2386-93.
9. Heerema NA, Arthur DC, Sather H, et al. Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Childrens Cancer Group. Blood 1994;83:2274-84.
10. Thirman MJ, Gill HJ, Burnett RC, et al. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations [see comments]. N Engl J Med 1993;329:909-14.
11. Taki T, Ida K, Bessho F, et al. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia. Leukemia 1996;10:1303-7.
12. Rubnitz JE, Link MP, Shuster JJ, et al. Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 1994;84:570-3.
13. Cimino G, Rapanotti MC, Rivolta A, et al. Prognostic relevance of ALL-1 gene rearrangement in infant acute leukemias. Leukemia 1995;9:391-5.
14. Pui CH, Behm FG, Downing JR, et al. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. J Clin Oncol 1994;12:909-15.
15. ISCN: guidelines for cancer cytogenetics, supplement to an international system for human cytogenetic nomenclature. In: Mitelman F, editor. Guidelines for Cancer Cytogenetics, Supplement to an International System for Human Cytogenetic Nomenclature. Basel, Switzerland:Karger, 1991;1-54.
16. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
17. Raimondi SC, Frestedt JL, Pui CH, et al. Acute lymphoblastic leukemias with deletion of 11q23 or a novel inversion (11) (p13q23) lack MLL gene rearrangements and have favorable clinical features. Blood 1995;86:1881-6.
18. Pui CH, Frankel LS, Carroll AJ, et al. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases [see comments]. Blood 1991;77:440-7.
19. Behm FG, Raimondi SC, Frestedt JL, et al. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. Blood 1996; 87:2870-7.
20. Broeker PL, Super HG, Thirman MJ, et al. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Blood 1996;87:1912-22.
21. Greaves MF: Infant leukaemia biology, aetiology and treatment. Leukemia 1996;10:372-7.
22. Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996;14:18-24.
23. Pinkel D. Selecting treatment for children with acute lymphoblastic leukemia. J Clin Oncol 1996;14:4-6.